234 related articles for article (PubMed ID: 34025683)
1. Nutrigenetic Interactions Might Modulate the Antioxidant and Anti-Inflammatory Status in Mastiha-Supplemented Patients With NAFLD.
Kanoni S; Kumar S; Amerikanou C; Kurth MJ; Stathopoulou MG; Bourgeois S; Masson C; Kannt A; Cesarini L; Kontoe MS; Milanović M; Roig FJ; Beribaka M; Campolo J; Jiménez-Hernández N; Milošević N; Llorens C; Smyrnioudis I; Francino MP; Milić N; Kaliora AC; Trivella MG; Ruddock MW; Medić-Stojanoska M; Gastaldelli A; Lamont J; Deloukas P; Dedoussis GV; Visvikis-Siest S
Front Immunol; 2021; 12():683028. PubMed ID: 34025683
[TBL] [Abstract][Full Text] [Related]
2. Effect of Mastiha supplementation on NAFLD: The MAST4HEALTH Randomised, Controlled Trial.
Amerikanou C; Kanoni S; Kaliora AC; Barone A; Bjelan M; D'Auria G; Gioxari A; Gosalbes MJ; Mouchti S; Stathopoulou MG; Soriano B; Stojanoski S; Banerjee R; Halabalaki M; Mikropoulou EV; Kannt A; Lamont J; Llorens C; Marascio F; Marascio M; Roig FJ; Smyrnioudis I; Varlamis I; Visvikis-Siest S; Vukic M; Milic N; Medic-Stojanoska M; Cesarini L; Campolo J; Gastaldelli A; Deloukas P; Trivella MG; Francino MP; Dedoussis GV;
Mol Nutr Food Res; 2021 May; 65(10):e2001178. PubMed ID: 33629536
[TBL] [Abstract][Full Text] [Related]
3. Mastiha has efficacy in immune-mediated inflammatory diseases through a microRNA-155 Th17 dependent action.
Amerikanou C; Papada E; Gioxari A; Smyrnioudis I; Kleftaki SA; Valsamidou E; Bruns V; Banerjee R; Trivella MG; Milic N; Medić-Stojanoska M; Gastaldelli A; Kannt A; ; Dedoussis GV; Kaliora AC
Pharmacol Res; 2021 Sep; 171():105753. PubMed ID: 34224858
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease.
Faghihzadeh F; Adibi P; Rafiei R; Hekmatdoost A
Nutr Res; 2014 Oct; 34(10):837-43. PubMed ID: 25311610
[TBL] [Abstract][Full Text] [Related]
5. Effect of a high-protein diet with β-cryptoxanthin supplementation on metabolic risk factors, oxidative and inflammatory biomarkers in non-alcoholic fatty liver disease (NAFLD): study protocol for a randomized controlled clinical trial.
Haidari F; Hojhabrimanesh A; Helli B; Seyedian SS; Ahmadi-Angali K
Trials; 2018 Nov; 19(1):634. PubMed ID: 30445988
[TBL] [Abstract][Full Text] [Related]
6. Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study.
Abenavoli L; Greco M; Milic N; Accattato F; Foti D; Gulletta E; Luzza F
Nutrients; 2017 Aug; 9(8):. PubMed ID: 28805669
[TBL] [Abstract][Full Text] [Related]
7. Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial.
Sharifi N; Amani R; Hajiani E; Cheraghian B
Endocrine; 2014 Sep; 47(1):70-80. PubMed ID: 24968737
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Phytosomal Curcumin in Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial.
Panahi Y; Kianpour P; Mohtashami R; Jafari R; Simental-Mendía LE; Sahebkar A
Drug Res (Stuttg); 2017 Apr; 67(4):244-251. PubMed ID: 28158893
[TBL] [Abstract][Full Text] [Related]
9. Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress.
Farhangi MA; Alipour B; Jafarvand E; Khoshbaten M
Arch Med Res; 2014 Oct; 45(7):589-95. PubMed ID: 25450583
[TBL] [Abstract][Full Text] [Related]
10. The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease.
Del Ben M; Polimeni L; Baratta F; Pastori D; Angelico F
Br J Clin Pharmacol; 2017 Jan; 83(1):88-95. PubMed ID: 26852185
[TBL] [Abstract][Full Text] [Related]
11. The effect of curcumin with piperine supplementation on pro-oxidant and antioxidant balance in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial.
Mirhafez SR; Farimani AR; Gholami A; Hooshmand E; Tavallaie S; Nobakht M Gh BF
Drug Metab Pers Ther; 2019 May; 34(2):. PubMed ID: 31145689
[TBL] [Abstract][Full Text] [Related]
12. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
Faghihzadeh F; Adibi P; Hekmatdoost A
Br J Nutr; 2015 Sep; 114(5):796-803. PubMed ID: 26234526
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress biomarkers in the serum and plasma of patients with non-alcoholic fatty liver disease (NAFLD). Can plasma AGE be a marker of NAFLD? Oxidative stress biomarkers in NAFLD patients.
Świderska M; Maciejczyk M; Zalewska A; Pogorzelska J; Flisiak R; Chabowski A
Free Radic Res; 2019 Aug; 53(8):841-850. PubMed ID: 31234658
[TBL] [Abstract][Full Text] [Related]
14. Linking the IL-17A immune response with NMR-based faecal metabolic profile in IBD patients treated with Mastiha.
Amerikanou C; Dimitropoulou E; Gioxari A; Papada E; Tanaini A; Fotakis C; Zoumpoulakis P; Kaliora AC
Biomed Pharmacother; 2021 Jun; 138():111535. PubMed ID: 34311533
[TBL] [Abstract][Full Text] [Related]
15. Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial.
Naeini F; Namkhah Z; Tutunchi H; Rezayat SM; Mansouri S; Jazayeri-Tehrani SA; Yaseri M; Hosseinzadeh-Attar MJ
Trials; 2021 Nov; 22(1):801. PubMed ID: 34774104
[TBL] [Abstract][Full Text] [Related]
16. Hesperetin ameliorates hepatic oxidative stress and inflammation
Li J; Wang T; Liu P; Yang F; Wang X; Zheng W; Sun W
Food Funct; 2021 May; 12(9):3898-3918. PubMed ID: 33977953
[TBL] [Abstract][Full Text] [Related]
17. Effects of Delta-tocotrienol Supplementation on Liver Enzymes, Inflammation, Oxidative stress and Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease.
Pervez MA; Khan DA; Ijaz A; Khan S
Turk J Gastroenterol; 2018 Mar; 29(2):170-176. PubMed ID: 29749323
[TBL] [Abstract][Full Text] [Related]
18. Nutrition and Genetics in NAFLD: The Perfect Binomium.
Meroni M; Longo M; Rustichelli A; Dongiovanni P
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340286
[TBL] [Abstract][Full Text] [Related]
19. Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial.
Ebrahimi-Mameghani M; Sadeghi Z; Abbasalizad Farhangi M; Vaghef-Mehrabany E; Aliashrafi S
Clin Nutr; 2017 Aug; 36(4):1001-1006. PubMed ID: 27475283
[TBL] [Abstract][Full Text] [Related]
20. Citrulline decreases hepatic endotoxin-induced injury in fructose-induced non-alcoholic liver disease: an ex vivo study in the isolated perfused rat liver.
Ouelaa W; Jegatheesan P; M'bouyou-Boungou J; Vicente C; Nakib S; Nubret E; De Bandt JP
Br J Nutr; 2017 Jun; 117(11):1487-1494. PubMed ID: 28637520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
